Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country Sort ascending
Application Due Date
Improving the Therapeutic Environment for Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Shared Decision-Making (SDM) in Lung Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines Italy
Cancer Registry
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Oncology Congo, The Democratic Republic
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease Australia, Canada, France, Germany, Italy, Japan, Korea, Spain
Title
Grant Type
Focus Area
Country Sort ascending
Application Due Date
Atopic Dermatitis Patient Education
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Addressing Health Disparities in Inflammatory Bowel Disease
Release Date:
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology USA
Implementing Updated Pneumococcal Immunization Recommendations in Adults
Release Date:
Review Process: Pfizer Internal
Quality Improvement Vaccines USA
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Growth Hormone Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Local Level Educational Grants Program to Increase Awareness and Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine USA
Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Artificial Intelligence/Machine Learning Research in Hemophilia
Release Date:
Review Process: Expert Review Panel
Research Rare Disease USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease USA